Novel transcript, antisense to XPO6

Novel transcript, antisense to XPO6" (ENSG00000310204, LOC124903669) is a human long non-coding RNA (lncRNA) gene that is transcribed in the antisense direction relative to the XPO6 gene[1][2][4]. It does not encode a protein and is described in gene annotation databases as a non-coding transcript variant and an RNA gene[1][2]. There is no evidence in publicly available resources or the literature linking it directly to therapeutic targeting, defined biological functions, disease roles, or known drug interactions[1][2][4]. Its primary characterization is as a genomic transcript and not as a protein, receptor, enzyme, transporter, or standard drug target[1][2][4]. \n\n**Additional Notes:** \n- This target is not misspelled or otherwise incorrect, according to recognized gene databases[1][2][4]. \n- It is distinct from the protein-coding gene XPO6 (Exportin-6), which is associated with nuclear export of actin and is a different, unrelated entity[3][5]. \n- There is no current evidence for clinical utility, biomarker status, or direct disease involvement for this lncRNA.

Other names

ENSG00000310204LOC124903669novel transcript antisense to XPO6lnc-GSG1L-6